A new class of isoxazole derivatives: The M 1-9 series of compounds with immunotropic activity

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 2, 2008, Pages 241-244

  Ma̧czyński, Marcin ^a   Zimecki, Michał ^b   Ryng, Stanisław ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Immunotropic activity; PHA

Indexed keywords

5 AMINO 3 METHYL 4 ISOXAZOLECARBOXYLIC ACID SEMICARBAZIDE; CARBOXYLIC ACID DERIVATIVE; CYCLOSPORIN A; IMMUNOMODULATING AGENT; ISOTHIOCYANIC ACID DERIVATIVE; ISOXAZOLE DERIVATIVE; PHYTOHEMAGGLUTININ; SEMICARBAZIDE DERIVATIVE; THIOSEMICARBAZIDE DERIVATIVE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

HUMANS; IMMUNOLOGIC FACTORS; ISOXAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 45849106106     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fischereder M., Kretzler M.: J. Nephrol. 17, 1366 (2004).
2. Ibrahim A., Park S., Feldman J., Karim A., Kharasch E.D.: Anesthesiology 96, 88 (2002).
3. Ryng S., Machoń Z., Wieczorek Z., Zimecki M., Głowiak T.: Arch. Pharm. Pharm. Med. Chem. 330, 319 (1997).
4. Ryng S., Zimecki M., Fedorowicz A., Koll A.: Pol. J. Pharmacol. 51, 257 (1999).
5. Ryng S., Zimecki M., Sonnenberg Z., Mokrosz M. J.: Arch. Pharm. Pharm. Med. Chem. 332, 158 (1999).
6. Ryng S., Zimecki M., Fedorowicz A., Koll A.: Quant. Struct. Act. Relat. 18, 236 (1999).
7. Ryng S., Sonnenberg Z., Zimecki M.: Arch. Immunol. Ther. Exp. 48, 127 (2000).
8. Fedorowicz A., Jezierska A., Ryng S.: Internet J. Chem. 4, 7 (2001).
9. Ryng S., Machoń Z., Wieczorek Z., Zimecki M.: Pharmazie 54, 359 (1999).
10. Ryng S., Zimecki M., Fedorowicz A., Jezierska A.: Arch. Pharm. Pharm. Med. Chem. 334, 71 (2001).
11. Jezierska A., Panek J., Ryng S., Fedorowicz A., Koll A.: Pol. J. Chem. 76, 1255 (2002).
12. Ma̧czyński M., Jezierska A., Zimecki M., Ryng S.: Acta Pol. Pharm. Drug Res. 60, 147 (2003).
13. Ma̧czyński M., Zimecki M., Drozd-Szczygieł E., Ryng S., Cell. Mol. Biol. Lett. 10, 613 2005).
14. Ma̧czyński M., Zimecki M., Ryng S.: Acta Pol. Pharm. 61, 82 (2004).
15. Hansen M.B., Nielsen S.E., Berg K.: J. Immunol. Methods 119, 203 (1989).
16. Ryng S, Zimecki M, Ma̧czyński M, Chodaczek G, Kociȩba M.: Pharmacol. Rep. 57, 195 (2006).
17. Zimecki M., Ryng S., Ma̧czyński M., Chodaczek G., Kociȩba M., Kuryszko J., Kaleta K.: Pharmacol. Rep. 58, 236 (2006).
18. Ruckemann K., Fairbanks C.D., Carrey E.A., Hawrylowocz C.M., Richards D.F., Kirschbaum B, Simmonds H.A.: J. Biol. Chem. 273, 21682 (1998).
19. Lang R., Wagner H., Heeg K., Transplantation 59, 382 (1995).